Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F56RZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,675
Award facts
- Contract value 100% obligated
- $19,675.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,675.20 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 10, 2025, with an ultimate completion date of December 11, 2025. This firm fixed price contract represents a non-competitive, non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product being delivered—RINVOQ ER (upadacitinib extended-release)—is a JAK inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the pharmaceutical and medical supply distribution services that AmerisourceBergen provides to support military and federal healthcare systems.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Defense Health Agency and other government healthcare systems. The company's IDC vehicle enables flexible delivery of a comprehensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs globally. This delivery order exemplifies the routine pharmaceutical procurement operations under the broader contract framework, positioning AmerisourceBergen as a key logistics partner for the Department of Defense's medical supply chain management.
Quick answers
Who was awarded contract SPE2DR26F56RZ?
SPE2DR26F56RZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F56RZ worth?
The government has obligated $19,675 on SPE2DR26F56RZ.
Is contract SPE2DR26F56RZ an order under another contract?
Yes. SPE2DR26F56RZ is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F56RZ competed?
The extent of competition for SPE2DR26F56RZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award